Comparison of insulin detemir and insulin glargine on glucose variability in type 1 and type 2 diabetes.

Comparison of insulin detemir and insulin glargine on glucose variability in type 1 and type 2 diabetes. - Comparison of insulin detemir and insulin glargine.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001562

Enrollment

Registered

2008-12-10

Start date

2008-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

conversion from insulin glargine to insulin detemir

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 1 and type 2 diabetic patients receiving intensive insulin therapy with insulin glargine.

Exclusion criteria

Exclusion criteria: patients who cannot record SMBG.

Design outcomes

Primary

Measure	Time frame
episode of hypoglycemia	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026